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GYNECOLOGY
Postpartum contraceptive use among women
with a recent preterm birth
Cheryl L. Robbins, PhD; Sherry L. Farr, PhD; Lauren B. Zapata, PhD;
Denise V. D’Angelo, MPH; William M. Callaghan, MD, MPH
OBJECTIVE: The objective of the study was to evaluate the associa-
tions between postpartum contraception and having a recent preterm
birth.
STUDY DESIGN: Population-based data from the Pregnancy Risk
Assessment Monitoring System in 9 states were used to estimate the
postpartum use of highly or moderately effective contraception (ster-
ilization, intrauterine device, implants, shots, pills, patch, and ring) and
user-independent contraception (sterilization, implants, and intra-
uterine device) among women with recent live births (2009e2011).
We assessed the differences in contraception by gestational age
(27, 28e33, or 34e36 weeks vs term [37 weeks]) and modeled
the associations using multivariable logistic regression with weighted
data.
RESULTS: A higher percentage of women with recent extreme preterm
birth (27 weeks) reported using no postpartum method (31%)
compared with all other women (15e16%). Women delivering
extreme preterm infants had a decreased odds of using highly or
moderately effective methods (adjusted odds ratio, 0.5; 95% confi-
dence interval, 0.4e0.6) and user-independent methods (adjusted
odds ratio, 0.5; 95% confidence interval, 0.4e0.7) compared with
women having term births. Wanting to get pregnant was more
frequently reported as a reason for contraceptive nonuse by women
with an extreme preterm birth overall (45%) compared with all other
women (15e18%, P < .0001). Infant death occurred in 41% of
extreme preterm births and more than half of these mothers (54%)
reported wanting to become pregnant as the reason for contraceptive
nonuse.
CONCLUSION: During contraceptive counseling with women who had
recent preterm births, providers should address an optimal pregnancy
interval and consider that women with recent extreme preterm birth,
particularly those whose infants died, may not use contraception
because they want to get pregnant.
Key words: contraception effectiveness, insurance, Medicaid, post-
partum, preterm birth
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I n 2012, 12% of all US births werepreterm (PTB; <37 weeks’ gesta-
tion),1 and preterm-related deaths are
the leading cause of infant mortality.2,3
Short interpregnancy intervals (IPI)
(ie, conception within 18 months of a
previous birth) are associated with
approximately 40% increased risk of
PTB (<37 weeks’ gestation), low birth-
weight, and small for gestational age4
and an increased risk of recurrent PTB.5
Short IPI has also been linked to se-
vere maternal complications such as
premature membrane rupture, abrup-
tion placentae, and placenta previa.6
Consequently, a Healthy People objec-
tive aims to reduce the proportion of
pregnancies with short IPI by 10% by
2020 (baseline, 33.1%, 2006e2010).7
Use of highly effective contracep-
tion postpartum, particularly user-
independent methods, is an important
strategy for reducing PTB, short IPI, and
recurrent PTB. User-independent meth-
ods include male and female sterilization
for those not desiring another pregnancy
and long-acting reversible contraceptives
(LARCs) for women who are not ready
for child-bearing but want to preserve
their fertility.8,9
The American College of Obstetri-
cians and Gynecologists encourages cli-
nicians to offer LARCs as first-line
contraception because they are revers-
ible, have very high effectiveness and
continuation rates (>99% of women
avoid an unintended pregnancy within
the first year of use), and are cost effec-
tive, even when used short term (12e24
months).8,10,11 Permanent contraceptive
methods (sterilization) are also highly
effective (>99%), whereas effectiveness
rates of other moderately effective, user-
dependent methods (ie, pills, patch,
ring, and shots) range from 91% to 94%
with typical use.10
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TABLE 1
Maternal characteristics among sample of postpartum (2e9 mo), nonpregnant, women by history of recent preterm birtha
Maternal characteristics
Recent term birth Recent preterm birth
P value (c2)
‡37 wks (n[ 25,946) 34e36 wks (n[ 3987) 28e33 wks (n[ 1872) £27 wks (n[ 606)
Weighted, % 95% CI Weighted, % 95% CI Weighted, % 95% CI Weighted, % 95% CI
91.3 90.9e91.6 6.46 6.1e6.8 1.72 1.6e1.8 0.56 0.5e0.6
Age, y .0330
19 8.4 7.9e8.9 8.3 6.8e10.1 10.1 8.3e12.4 7.9 5.5e11.2
20e24 23.5 22.8e24.3 23.0 20.7e25.5 23.6 20.8e26.7 30.4 24.9e36.6
25e29 31.5 30.6e32.3 29.8 27.2e32.6 26.5 23.5e29.7 24.9 20.5e29.9
30e34 24.3 23.5e25.1 24.5 22.1e27.1 23.9 20.8e27.4 26.1 21.1e31.8
35 12.3 11.8e12.9 14.3 12.4e16.3 15.8 13.7e18.3 10.8 8.1e14.2
Race/ethnicity < .0001
White, non-Hispanic 72.6 72.0e73.3 71.5 69.1e73.7 63.8 60.3e67.2 57.4 51.5e63.1
Black, non-Hispanic 9.8 9.5e10.2 14.1 12.5e15.9 19.6 17.1e22.4 27.6 22.3e33.5
Other, non-Hispanic 5.6 5.2e6.0 5.0 4.0e6.2 6.9 4.5e10.3 4.9 3.4e7.1
Hispanic 12.0 11.5e12.5 9.5 8.2e10.9 9.7 8.3e11.4 10.1 7.7e13.2
Education, highest level .0001
Less than 12th grade 14.4 13.8e15.1 16.3 14.2e18.7 16.7 14.4e19.4 16.4 11.7e22.4
12th grade, GED, or
high school graduate
24.6 23.8e25.4 27.2 24.6e29.9 29.3 26.3e32.5 35.7 30.1e41.7
Some college or more 61.0 60.1e61.9 56.5 53.6e59.3 54.0 50.5e57.5 48.0 42.2e53.8
Household income, dollars < .0001
<10,000 20.3 19.6e21.1 24.8 22.3e27.4 29.3 26.2e32.6 29.9 24.3e36.1
10,000e19,999 15.8 15.1e16.5 16.0 13.9e18.3 16.2 13.3e19.7 20.6 16.4e25.6
20,000e34,999 17.3 16.7e18.1 15.3 13.4e17.4 16.8 14.6e19.4 18.9 14.7e23.9
35,000e49,999 11.5 10.9e12.1 10.0 8.6e11.7 9.3 7.7e11.2 8.1 5.8e11.0
50,000 35.1 34.3e36.0 34.0 31.3e36.7 28.4 25.4e31.5 22.6 18.4e27.5
Marital status < .0001
Not married 34.1 33.3e35.0 38.7 35.9e41.6 43.6 40.1e47.3 53.6 47.8e59.3
Married 65.9 65.0e66.7 61.3 58.4e64.1 56.4 52.8e59.9 46.4 40.7e52.2
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TABLE 1
Maternal characteristics among sample of postpartum (2e9 mo), nonpregnant, women by history of recent preterm birtha (continued)
Maternal characteristics
Recent term birth Recent preterm birth
P value (c2)
‡37 wks (n[ 25,946) 34e36 wks (n[ 3987) 28e33 wks (n[ 1872) £27 wks (n[ 606)
Weighted, % 95% CI Weighted, % 95% CI Weighted, % 95% CI Weighted, % 95% CI
Health insurance at delivery .0001
Uninsured 1.8 1.5e2.1 2.0 1.4e2.9 2.0 1.2e3.3 3.2 1.8e5.8
Medicaid 42.8 41.9e43.7 43.5 40.6e46.3 49.8 46.3e53.3 53.1 47.2e53.8
Otherb 8.2 7.7e8.7 10.3 8.5e12.4 9.0 7.3e10.9 9.5 7.1e12.8
Private 47.3 46.4e48.2 44.3 41.4e47.1 39.3 36.0e42.7 34.2 29.1e39.7
Prenatal care < .0001
None 0.4 0.3e0.5 1.6 1.0e2.5 2.8 1.9e4.2 3.9 1.9e7.9
Late 17.1 16.5e17.9 13.4 11.8e15.2 17.5 15.0e20.4 17.8 13.5e23.1
Early 82.4 81.7e83.1 85.0 83.1e86.7 79.7 76.7e82.4 78.3 72.7e83.1
Current smoker < .0001
Yes 18.9 18.1e19.6 24.7 22.1e27.5 23.0 20.2e26.1 23.6 18.9e29.1
No 81.2 80.4e81.9 75.3 72.5e77.9 77.0 73.9e79.8 76.4 70.9e81.2
Previous live births, n .0001
0 39.4 38.5e40.3 38.3 35.5e41.1 43.4 40.0e46.9 41.2 35.7e46.9
1e2 49.7 48.8e50.6 47.4 44.5e50.3 41.8 38.3e45.4 43.3 37.7e49.2
3 10.9 10.3e11.5 14.3 12.4e16.5 14.8 12.6e17.3 15.5 10.8e21.8
Previous preterm birthc < .0001
Yes 4.0 3.5e4.6 14.2 11.0e18.1 17.8 12.5e24.8 13.6 9.4e19.3
No 96.0 95.4e96.5 85.8 81.9e89.0 82.2 75.2e87.5 86.4 80.8e90.6
Recent live-born baby died < .0001
Yes 0.1 0.1e0.2 0.3 0.1e0.5 2.0 1.3e4.6 40.7 34.7e47.1
No 99.9 99.8e99.9 99.7 99.5e99.9 98.0 95.4e98.7 59.3 52.9e63.4
CI, confidence interval; GED, general education degree.
a Based on Pregnancy Risk Assessment Monitoring System, 9 US states, 2009e2011 (n¼ 32,411); b Includes Tri-Care, other military, Indian Health Services, state-specific Children’s Health Insurance Plan, Children’s Health Insurance Plan; c Among multiparous
women only (n ¼ 14,068).
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Although several studies have exam-
ined contraceptive methods used post-
partum,12-15 none have focused on
womenwith a recent PTB, a group that is
at risk of future PTB and in need of
highly effective contraception to prevent
short IPI and reduce recurrent PTB. We
examined the prevalence of postpartum
contraceptive use among women with
recent live births and explored the asso-
ciations between recent PTB and the
consequent use of highly andmoderately
effective methods. We also investigated
whether associations vary by insurance
type and examined the reasons for con-
traceptive nonuse.
MATERIALS AND METHODS
This analysis is based on data from
the Pregnancy Risk Assessment Moni-
toring System (PRAMS), an ongoing
population-based survey of women with
live births in the past 2e9 months. The
PRAMS research design and survey
methods have been described else-
where,16 and additional details are
available from the PRAMS web site
(http://www.cdc.gov/prams).
Briefly, each participating state draws
a stratified random sample from birth
certificates and mails up to 3 surveys to
each selected participant. Women who
do not respond to the mailings are fol-
lowed up by telephone. The data are
weighted to account for sampling frame,
noncoverage, and participant nonre-
sponse, thus allowing for population-
based inferences. The PRAMS protocol
was approved by the Centers for Disease
Control and Prevention’s Institutional
Review Board, and participating states
approved the study analysis plan.
Data
PRAMS surveys comprise core questions
that are asked by all participating sites
and standard optional questions that
sites may choose to add. For this analysis,
we analyzed 2009e2011 data from 9
states (Arkansas, Colorado, Michigan,
Nebraska, Ohio, Oregon, Rhode Island,
Tennessee, and Utah) that asked the
optional question about specific contra-
ceptive methods used postpartum and
achieved an overall weighted response
rate of 65% or greater.
Measures
We estimated gestational age using the
clinical estimate reported on the birth
certificate and categorized gestational
age as term births (37 weeks) and PTB
(34e36 weeks, 28e33 weeks, and 27
weeks [extreme PTB]). The gestational
age categories were selected a priori.
To describe postpartum contraceptive
use, we examined responses to the
following questions: “Are you or your
husband or partner doing anything now
to keep from getting pregnant?” and
“What kind of birth control are you or
your husband or partner using now to
keep from getting pregnant?” Because
respondents could report multiple
methods, the most effective method of
all responses was selected.10
Contraceptive use was categorized
according to effectiveness.10
 Highly and moderately effective
methods were those with which fewer
than 10% of women have an unin-
tended pregnancy within the first year
of use: permanent methods (tubal
ligation or vasectomy) and LARCs
(intrauterine device or contraceptive
implant) and moderately effective
user-dependent methods (shots, pill,
patch, and ring).
 Less effective methods were those
with which 10% or more of women
have an unintended pregnancy within
the first year of use: male and female
condoms, diaphragm, cervical cap,
sponge, emergency contraception,
rhythm, withdrawal, and other.
 No contraceptive method (nonuse)
was coded when women answered no
to current contraceptive use or re-
ported that their only method was
abstinence.
All nonusers were asked about reasons
for not using contraceptives, specifically,
“What are your reasons or your hus-
band’s or partner’s reasons for not doing
anything to keep from getting pregnant
now?” Multiple close-ended responses
were allowed and included the following
responses: “I am not having sex,” “I want
to get pregnant,” “I don’t want to use
contraception,” “My husband or partner
doesn’t want to use anything,” “I don’t
think I can get pregnant,” “I can’t pay for
birth control,” and “other reason.” Re-
spondents also had the option to write in
a response.
Analysis
Of 37,089 respondents, 4678 (12.6%)
were excluded because of a current
pregnancy or hysterectomy (0.6%) or
missing information on postpartum
contraceptive method (2.8%) or cova-
riates (9.2%). Women who reported
abstinence were included in our analysis
as nonusers because 90% of postpartum
women resume sexual activity by 4
months postpartum17 and hence are at
risk for pregnancy.
Our final analytical sample included
32,411 nonpregnant women with recent
live births and data on all covariates. We
estimated the prevalence of maternal
characteristics and postpartum contra-
ceptive use (highly or moderately effec-
tive methods, less effective methods, and
no method) stratified by PTB group and
used c2 tests to assess the statistical dif-
ferences (P < .05).
Using a multivariable logistic regres-
sion to control for potential con-
founders, we evaluated the associations
between recent PTB and 2 measures of
postpartum contraceptive use: (1) any
highly or moderately effective contra-
ceptivemethod (vs less effectivemethods
and no method) and (2) highly effective
user-independent methods (vs moder-
ately effective methods, less effective
methods, and no method). Potential
confounders identified from the litera-
ture were age, race/ethnicity, education,
income, health insurance, marital status,
prenatal care, parity, and smoking.
We conducted sensitivity analyses of
the multivariable models among sub-
groups of women who expressed no
concerns about potential infertility (n ¼
32,309) and multiparous women, addi-
tionally controlling for pregnancy
intention and previous PTB (n ¼
14,068). We also examined associations
between infant death and contraceptive
use among women who had extreme
PTB (n ¼ 517).
We assessed effect modification by
insurance type at delivery (private,
Medicaid, other, none) for the full
ajog.org Gynecology Research
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sample by examining statistical signifi-
cance of interaction terms between PTB
and insurance type for both outcomes (P
< .05). All analyses were conducted us-
ing weighted data and STATA 13 (2013;
StataCorp LP, College Station, TX) to
adjust for the complex survey design,
thus allowing for population inferences.
RESULTS
A larger percentage of excluded women
had recent PTB (10.4%) compared with
the analytical sample (8.7%; P ¼ .005)
and reported no postpartum contracep-
tive method (24.4% vs 8.7%; P< .0001).
Of excluded women, recent PTB was
even higher among the subset of
excluded pregnant women (14.1%).
Excluded women were also more likely
to be young, minority race/ethnicity, low
income, and unmarried and reported
late entry into prenatal care and less
likely to be college educated or privately
insured.
Prevalence of having a recent PTB was
8.7%, of which extreme PTB accounted
for less than 1% (Table 1). Compared
with womenwho had recent term births,
a higher percentage of women with
recent PTBs were non-Hispanic black,
low income, unmarried, and current
cigarette smokers. Additionally, a higher
percentage of women with recent PTBs
reported having had 3 or more previous
live births, previous PTB, no prenatal
care for the most recent live birth, and
death of themost recent live-born infant.
A smaller percentage of women with
recent PTB were college educated or had
private insurance (compared with
women with recent term births). Infant
death varied by gestational age of the
recent birth: 41% at 27 weeks or less, 2%
at 28e33 weeks, and less than 1% for 34
weeks or longer.
Postpartum contraceptive use varied
by gestational age of the most recent
birth (Figure, P < .0001). Nearly half of
all women with a recent PTB (39%) re-
ported using a less effective method or
no method at all. Except for those with a
recent extreme preterm birth, most
women reported using moderately
effective user-dependent methods.
Women with extreme PTB most
frequently reported no method (31%),
at approximately twice the prevalence
that was reported by all other groups of
women (15e16%).
Women with extreme PTB also had
the lowest prevalence of using moder-
ately effective user-dependent methods
(25%), LARCs (10%), and permanent
contraception (8%), compared with all
other groups of women. In subgroup
analyses among women with an extreme
PTB, a higher percentage of women
whose infants died used no method
(42%) compared with their counterparts
whose infants survived (19%, P ¼ .0003;
not shown).
After adjusting for confounders,
women with extreme PTB had half the
odds (adjusted odds ratio, 0.5) of using
any highly or moderately effective
method or user-independent methods,
compared with women who had recent
term births (Table 2). However, point
estimates for other women with PTB
(28e33 and 34e36 weeks) did not sta-
tistically differ from those with term
births. The point estimates for using any
highly or moderately effective method,
or user-independent methods among
women with extreme PTB were un-
changed in sensitivity analyses for the
subsample of women who expressed no
concerns about potential infertility or
after controlling for previous PTB and
pregnancy intention for the subsample
of multiparous women (not shown). We
found no evidence of effect modification
by insurance type.
Among womenwith extreme PTB, the
most frequently reported reason for
contraceptive nonuse was the desire to
get pregnant (45%), and this reason was
more prevalent when limited to those
with an extreme PTB who lost their in-
fants (54%, data not shown). Among
women who were not using any contra-
ception, lower percentages of women
FIGURE
Percentage of postpartum contraceptive method type
This figure depicts the prevalence of postpartum contraception use (permanent, LARCs, highly and
moderately effective user-dependent methods, less effective methods, none) stratified by the most
recent birth outcome (term or preterm: 34e36 weeks, 28e33 weeks, 27 weeks).
LARC, long-acting reversible contraceptive.
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with recent PTB at 28e33 weeks and 27
weeks or less reported not wanting to use
contraception (21% and 17%, respec-
tively) than women who had term births
(35%, Table 3).
Many women with a recent term birth
(29%) or PTB (17e28%) alike reported
reasons for contraception nonuse other
than those in the explicit response op-
tions. Believing that one could not get
pregnant, current breast-feeding, and
pregnancy ambivalence or desire were
the most frequent reasons noted among
women who reported other response.
Financial barriers to obtaining birth
control were infrequently reported as a
reason by all groups (6e11%).
COMMENT
Overall, nearly half of all women with
recent PTB reported using less effective
contraceptive methods or no method.
Womenwith a recent extreme PTB had a
reduced odds of using any highly or
moderately effective method or user-
independent methods, compared with
women with recent term births. We also
found that a higher percentage of
women with extreme PTB whose infants
died used no method (42%) compared
with their counterparts whose infants
survived (19%). This finding suggests
that the observed associations between
extreme PTB and contraceptive effec-
tiveness are mediated by infant death.
The associations between the gesta-
tional age of the recent birth and the use
of any highly or moderately effective
method did not differ according to in-
surance status. Reasons for not using
contraception differed by a recent his-
tory of PTB. Of women whose recent
extreme PTB resulted in infant death,
more than half reported not using
contraception because they wanted to
become pregnant. Wanting to get preg-
nant was more frequently reported
among women with a recent extreme
PTB than among women who had term
births. Financial barriers were infre-
quently reported for contraceptive
nonuse among all women.
PTB is a strong predictor of recurrent
PTB,18 and our finding that approxi-
mately half of women with recent PTB
were using less effective methods or no
contraception should serve as a call to
action. Many women with a recent PTB,
particularly those whose babies died,
want to get pregnant and therefore do
not use contraception postpartum. Pro-
viders need to consider this possibility
during contraceptive counseling.
Contraceptive counseling on the
negative consequences of short IPI
and early postpartum access to highly
effective contraception, such as LARCs
or sterilization, if appropriate and
desired by the woman, is a critical
strategy for reducing short IPI and
PTB.19,20 Providers can also use the
contraceptive counseling moment as an
opportunity to correct misperceptions
about impaired postpartum fertility.
This is important because postpartum
women may underestimate their fertility
after birth.21
The earliest and possibly best oppor-
tunity for initiating highly effective
contraception postpartum is before
hospital discharge after delivery. There
are a couple of reasons for this. First,
sexual activity frequently occurs before
the postpartum visit.22 Second, the
postpartum period can be a chaotic time,
and new mothers can be narrowly
focused on their newborns during that
time. This may be particularly true for
women with critically ill infants under-
going intensive care. As a result of this
intense focus on newborns, women may
neglect their own needs during the
postpartum period. For example, a large
study of Medicaid claims in California
found less than half of postpartum
women (41%) received contraceptive
services within the first 3 months of
giving birth.23 Although it is ideal to
provide immediate access to highly
TABLE 2
aORs and 95% CIs modeling associations between postpartum contraceptive methods and history of recent
preterm birtha
Postpartum use of contraception
Highly or moderately effective
contraceptive methodsb
Highly effective user-independent
contraceptive methodsc
Most recent live birth,
wks of gestation aORd 95% CI aOR 95% CI
37 Reference Reference
34e36 1.1 1.0e1.3 1.1 0.9e1.2
28e33 1.1 1.0e1.3 1.2 1.0e1.4
27 0.5 0.4e0.6 0.5 0.4e0.7
aOR, adjusted odds ratio; CI, confidence interval.
a Based on Pregnancy Risk Assessment Monitoring System, 9 US states, 2009e2011 (n¼ 32,411); b Includes tubal ligation, vasectomy, intrauterine devices, implants, shots, pill, patch, and ring
(vs male and female condoms, diaphragm, cervical cap, sponge, emergency contraception, rhythm, withdrawal, other, and no method); c Includes tubal ligation, vasectomy, intrauterine devices, or
implants (vs shots, pill, patch, and ring, male and female condoms, diaphragm, cervical cap, sponge, emergency contraception, rhythm, withdrawal, other, and no method); d Adjusted for age,
race/ethnicity, education, income, insurance, marital status, prenatal care entry, parity, and smoking.
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effective contraception after delivery,
unfortunately, the global fee for delivery-
related care typically does not include
reimbursement for contraception.24
The postpartum visit provides
another important opportunity for
contraceptive counseling and contra-
ception initiation. Zutshi et al25 recently
investigated risk factors for short IPI
among women who attended an
obstetrics-gynecology residence clinic in
a large community hospital and found
women who received postpartum visits
had lower rates of pregnancy within 18
months of delivery.
Highly effective contraception can be
initiated at the postpartum visit without
waiting for menses to resume if the
clinician is reasonably certain the
woman is not pregnant. This strategy,
known as Quick Start, is recommended
by the Centers for Disease Control and
Prevention26,27 and has been shown to
be safe and effective.28,29 Unfortunately,
nearly one fourth of women who deliver
do not return for postpartum visits.30
For these women, Quick Start of
contraception could be offered at other
medical visits for the mother or her in-
fant during the postpartum period.
The findings from our study are sub-
ject to the following limitations. First,
PRAMS data were not available for all
states; the 9 states in our analysis repre-
sent approximately 14% of US births;
white women are overrepresented and
non-Hispanic black and Hispanic
women are underrepresented compared
with the US population.31 Second,
PRAMS surveys only women who
delivered live infants; we cannot
comment on women who had stillbirths
or miscarriages. Third, misclassification
is possible because some women use
contraceptive methods other than those
specified by the survey options. For
example, PRAMS does not assess breast-
feeding exclusivity. Therefore, women
relying on lactation amenorrhea may be
misclassified as nonusers. Fourth, selec-
tion bias is possible because nearly 13%
women were excluded, and larger per-
centages of excluded women had recent
PTB compared with the analytic sample.
Fifth, we did not exclude women who
reported that they were not currently
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sexually active because we assumed that
sexual activity wouldmost likely resume,
putting them at risk of short IPI. If
anything, this would lead to un-
derestimates of contraceptive method
types compared with those reported by
other studies that excluded abstinent
women. However, our estimates gener-
ally aligned with ranges reported by
other studies.
Despite these limitations, the study
results suggest that women with a recent
PTB may benefit from contraceptive
counseling on the negative consequences
of short IPI. Additionally, contraceptive
providers should consider that women
whose infants died may want to become
pregnant again relatively soon and
address optimal pregnancy intervals
with sensitivity.
Contraceptive counseling that en-
courages the use of highly effective con-
traceptive methods and dispels myths
about impaired fertility during the
postpartum period is important for all
postpartum women, especially those
with a recent history of PTB. Patient and
institutional barriers to using highly
effective contraception postpartum need
to be addressed, and research should
explore whether womenwith recent PTB
encounter additional barriers. Use of
highly effective postpartum contracep-
tion may be improved with additional
education about fertility during the
postpartum period and with increased
opportunities to receive contraceptive
counseling at all medical visits for
mothers and their infants during the
postpartum period. -
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